Viralgen Vector Core

Viralgen vector core is a partnership uniquely positioned in the cdmo industry to bring forward a robust suspension platform for aav production in a facility custom designed to bring therapies to. Viralgen vector core is a partnership uniquely positioned in the cdmo industry to bring forward a robust suspension platform for aav production in a facility custom designed to bring therapies to market as quickly as possible. Sv40 sequences are not present in the pro10 cell line.
viralgen vector core

Viralgen vector core has licensed the pro10 cell line and manufacturing process from askbio.

Viralgen vector core. Pro10 cell line is derived from hek293 cells and shows high yields across a wide range of serotypes and multiple chimeric and novel capsids. Viralgen provides an integrated set of development manufacturing and testing services and the capacity required for clinical and commercial aav vector manufacturing. Viralgen vector core is a partnership uniquely positioned in the cdmo industry to bring forward a robust suspension platform for aav production in a facility custom designed to bring therapies to market as quickly as possible. Viralgen vector core unique center in europe for the production of viral vectors together with the us company asklepios biopharmaceutical inc askbio columbus is developing a production facility of adeno associated viruses aav that is located in the science and technology park of gipuzkoa in san sebastian.